EFFECTS OF SGLT-2 INHIBITORS AND GLP-1 AGONISTS ON FATTY LIVER INDEX IN TYPE 2 DIABETIC PATIENTS
AACE ePoster Library. Negro R. 04/25/19; 262873; 633548
Roberto Negro
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
{{ help_message }}
{{filter}}